화일약품 Rights issue filings (유상증자)

Fields as filed (DART)

Values are exactly as filed. We did not round or edit them. A hyphen in the original means no value.

New shares, common (shares)

1,379,690

New shares, other classes (shares)

-

Par value per share (KRW)

5,000

Total shares before issue, common

8,417,584

Total shares before issue, other classes

-

Use of funds, facilities (KRW)

-

Use of funds, business acquisition (KRW)

-

Use of funds, operations (KRW)

9,999,993,120

Use of funds, debt repayment (KRW)

-

Use of funds, buying other companies' securities (KRW)

-

Use of funds, other (KRW)

-

Issue method

제3자배정증자

Our calculation

New share ratio = new shares / total shares before issue x 100

New share ratio (common): 1,379,690 / 8,417,584 x 100 = 16.39 percent

This measures how much the share count grows. A large ratio is not bad and a small one is not good.

Other filings by the same company

• 화일약품KOSDAQ 2026-10-02

  [기재정정]주요사항보고서(전환사채권발행결정)

• 화일약품KOSDAQ 2026-09-15

  주요사항보고서(전환사채권발행결정)

A corrected report gets its own filing number. If numbers differ, the later filing is the newer one.